Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Mature, or PrematureToday 20:37
Hi All
It may appear that we are not out there promoting the heck out of what we have been working on for 4 years (yes, 4 years). Wastewater based epidemiology (study of epidemics in sewage) has been around for decades.
COVID19 has been around for 7 months. At the last count there were 115 vaccine targets, lots of test-kit manufacturers and 10's of therapies to treat the disease out there trying around the clock to deliver the silver bullet.
We are fortunate that we have a 4 year head start to deliver an instant alert system when hundreds of PhD and under graduates are jumping down manholes taking samples and running back to their labs to use a gene sequencing protocol.
We just got the keys to the CL3 laboratory, having taken 8 weeks looking and 5 weeks passing all the qualifications to work on SARS-CoV-2 in this secure facility on health, safety issues for both our Labskin and how we deal with disposable virus in the real world when we do roll out the RAWTest units.
It takes, and will take weeks to get through all this before we can even test this in the field. We will get lots right and somethings wrong, but we have to get them right in the secure lab, not expose any user in the field.
So PR and IR around this is building. There are plenty of the right people who know what we are doing and once it's done, it will be the right time to let the world knkw it is ready.
So long term investors, supporters, researchers will have been following what we are doing and building out to deliver. Others may be frustrated, but all the pieces are put in place. Our collaboration with Modern Water and their existing trusted network of installed Microtox units. The clients who have used them for 30 years around the world. ecowaterOS consortium who are involved in miniaturising it, universities who have been testing it, OEM producers who can scale it to mass production level on multiple continents and clients who know they need it.
It is easy to get it in the papers, it is better to get it into production for a market that has, and is building pent up demand for instant detection and identification of pathogenic bacteria and viruses for the long term, when long after COVID19, wastewater based epidemiology will still be an important are for us, when all the vaccine chasers are gone
All the above is in the public domain. There is nothing material in what is stated above, that is not in our RNS over the last two or three months
Thanks for the update.
I’m building a stake in the company just now as see the potential, good that you post on here and agree the focus should be on the ability to product-ionise the offering and build the revenues in a safe manner. These boards tend to attract people wanting the share price to move everyday to benefit their trading position.
Hope you and the team are doing well, I’m sure you are each under a huge amount of stress - it’ll be worth it in the long term!
Best wishes,
Bobby
Just what I wanted to hear - doing the right things at the right time in the right order!!